RxDoctor Payments Data

Michael Ghannam, MD

Clinical Cardiac Electrophysiology · Ann Arbor, MINPI 1023301900

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (42.4%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Boston Scientific at 37.5% of the total. Reporting peaked in 2024 at $11,082 and has fallen 96.6% since, to $380 in 2025.

$19,820in general payments, 2019–2025

Across 64 payments — averaging $309.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$7K
  • Abbott$4K
  • Medical Device Business Services, Inc.$4K
  • Medtronic$2K
  • Biotronik Inc.$2K
  • Impulse Dynamics (USA) Inc.$235
  • plus $130 from 1 others
$32,894in research payments, 2019–2025

Across 4 payments — averaging $8223.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$33K

What the payments were for

  • Consulting fees$7,57538%
  • Speaking & faculty fees$1,2006%
  • Travel & lodging$8,41142%
  • Food & beverage$2,63413%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,820 in reported general payments places this provider in the 55th percentile of 105 clinical cardiac electrophysiology providers in Michigan.

See all clinical cardiac electrophysiology providers in Michigan

Medicare billing

Part B allowed, 2024
$113,802
Medicare patients
516
Services billed
933

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban156$181,184
XareltoRivaroxaban28$35,607
Amiodarone Hcl51$1,919
Flecainide Acetate27$1,279
Metoprolol Succinate68$1,105
Diltiazem 24hr Er (Cd)Diltiazem Hcl15$569
Metoprolol Tartrate27$352
ClopidogrelClopidogrel Bisulfate21$308
Carvedilol12$166

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →